Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

13.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.1K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

5.9K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
2.4K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

867
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
867

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research Advances on Targets and Mechanisms in Cancers Complicated by Cardiovascular Diseases.

OncoTargets and therapy·2026
Same author

Direct contact with natural killer cells reprograms monocyte-derived dendritic cells into a tolerogenic phenotype.

ImmunoHorizons·2026
Same author

Molecular mechanisms and genic resources responsive to salinity stress and their applications in maize and other crop breeding.

Science bulletin·2026
Same author

Tough asymmetric thermochromic ionogels via dynamic in situ phase separation for dual-modal smart optical switching.

Nature communications·2026
Same author

Progressive Backmapping of Highly Coarse-Grained Protein Models.

bioRxiv : the preprint server for biology·2026
Same author

H3K27me3-mediated chromatin remodeling governs salt tolerance in cotton via Na<sup>+</sup>/K<sup>+</sup> homeostasis modulation.

Journal of advanced research·2026
Same journal

Peritoneal metastasis in pancreatic cancer: molecular mechanisms, microenvironmental remodeling, and emerging intraperitoneal interventions.

Frontiers in molecular biosciences·2026
Same journal

Insights from LC-MS-based cerebrospinal fluid metabolomics in tuberculous meningitis.

Frontiers in molecular biosciences·2026
Same journal

Emerging roles of Notch signaling in the tumor microenvironment of digestive system cancers.

Frontiers in molecular biosciences·2026
Same journal

Adenosine metabolism as an endogenous protective mechanism in response to upstream ischemic injury.

Frontiers in molecular biosciences·2026
Same journal

Bound or unbound: mapping and monitoring receptor oligomerization by time-resolved fluorescence live-cell imaging.

Frontiers in molecular biosciences·2026
Same journal

Interaction of diosmetin, diosmin and diosmetin-7-O-glucoside with human erythrocytes, their model membrane, hemoglobin and redox-active metal ions.

Frontiers in molecular biosciences·2026
See all related articles

Related Experiment Video

Updated: Sep 4, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

509

Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery.

Kyle McKay1, Nicholas B Hamilton1, Jacob M Remington1

  • 1Department of Chemistry, University of Vermont, Burlington, VT, United States.

Frontiers in Molecular Biosciences
|July 18, 2022
PubMed
Summary
This summary is machine-generated.

We developed an essential dynamics ensemble docking (EDED) approach to identify key protein pocket conformations for drug discovery. This method improves virtual screening accuracy for targeting G protein-coupled receptors (GPCRs), like the PAC1 receptor.

Keywords:
PAC1 receptorantagonistcomputer aided drug designmolecular dynamicsprincipal component analysisvirtual screening

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

320
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Related Experiment Videos

Last Updated: Sep 4, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

509
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

320
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Pharmacology

Background:

  • Targeting G protein-coupled receptors (GPCRs) with small molecules requires accurate protein structures, which are often lacking.
  • Existing ensemble docking methods need improved model selection for efficiency and accuracy in drug discovery.

Purpose of the Study:

  • To develop a novel ensemble docking approach utilizing protein essential dynamics for improved virtual screening.
  • To apply this method to identify small-molecule antagonists for the PAC1 receptor, a stress-regulating class B GPCR.

Main Methods:

  • Developed an essential dynamics ensemble docking (EDED) approach to select relevant protein pocket conformations.
  • Applied EDED to a PAC1 receptor homology model, selecting four representative structures from simulations.
  • Screened millions of compounds from the ZINC database and validated compounds against selected PAC1 models.

Main Results:

  • The EDED approach effectively reduced false negatives in virtual screening.
  • Improved accuracy in identifying potent small-molecule compounds for PAC1 receptor targeting.
  • Demonstrated the utility of EDED with a limited number of representative protein models.

Conclusions:

  • The EDED methodology enhances virtual screening for GPCR targets, even with limited structural data.
  • This approach offers a cost-effective strategy for discovering small molecules against GPCRs, including those lacking experimental structures.